Sean Maduck

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CORT

Current role

2 calls Latest call 2026-04-30

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Corcept Therapeutics Inc (CORT)	President	$648,860	$261,200	$111,995	$5,163,087	—	$23,500	$6,208,642
2024	Corcept Therapeutics Inc (CORT)	President	$626,148	$471,120	$46,684	$2,804,219	—	$23,000	$3,971,171
2023	Corcept Therapeutics Inc (CORT)	President	$601,583	$422,800	$97,288	$2,764,760	—	$22,500	$3,908,931
2022	Corcept Therapeutics Inc (CORT)	President, Corcept Endocrinology	$572,917	$230,000	$23,954	$2,866,685	—	$20,500	$3,714,056
2021	Corcept Therapeutics Inc (CORT)	President, Corcept Endocrinology	$519,451	$309,375	—	$3,716,355	—	—	$4,545,181
2020	Corcept Therapeutics Inc (CORT)	President, Corcept Endocrinology	$474,380	$214,157	—	$2,508,404	—	—	$3,196,941
2019	Corcept Therapeutics Inc (CORT)	Chief Commercial Officer	$456,133	$308,881	—	$1,476,276	—	—	$2,241,290
2018	Corcept Therapeutics Inc (CORT)	Chief Commercial Officer	$436,667	$198,000	—	$2,171,400	—	—	$2,806,067
2017	Corcept Therapeutics Inc (CORT)	Senior Vice President, Commercial	$397,917	$320,000	—	$2,036,818	—	—	$2,754,735

Earnings-call appearances and filed executive appointments or departures, newest first.